| EVOTEC SE INH O.N. |
| Deutschland |
| Gesundheit |
| DE0005664809 / 566480 |
| EVT (Frankfurt) |
| FRA:EVT, ETR:EVT, EVT:GR |
| https://www.evotec.com/ |
|
Evotec SE is a leading life science company specializing in drug discovery and development for pharmaceutical and biotechnology partners. Founded in 1993 in Hamburg, Germany, it operates through two key segments: EVT Execute, which delivers integrate..
>Volltext.. |
| 485.08 Mio. EUR |
| 565.97 Mio. EUR |
| 742.28 Mio. EUR |
| -17.23 Mio. EUR |
| -186.73 Mio. EUR |
| -1.05 EUR |
| 497.88 Mio. EUR |
| 308.98 Mio. EUR |
| -91.43 Mio. EUR |
| 1.4 |
| -5.03% |
| -13.66% |
| - |
| - |
| - |
| - |
| EVOTEC |
| 20.11.26 |
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|